High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia
NCT: NCT07734662 · COMPLETED
Brief Summary
This randomized crossover clinical trial aims to verify and compare the effects of high-intensity (HIG) and preferred-intensity (PIG) resistance training on the health of women with fibromyalgia (FM). Secondary objectives include verifying differences after 4, 8, and 16 sessions, as well as evaluating the proportion of participants who achieve the minimal clinically important difference in the disease impact/severity outcome. Patients included in the study will be randomized into two groups: HIG and PIG. Sixteen training sessions will be conducted twice a week, with each session lasting approximately 60 minutes. Subsequently, patients will undergo a minimum 8-week washout period (detraining) and will then be allocated to the other intervention group. The primary outcome is disease impact evaluated using the Revised Fibromyalgia Impact Questionnaire (FIQR). Secondary outcomes include mood states evaluated by the Brunel Mood Scale (BRUMS), sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI), anxiety levels evaluated with the Beck Anxiety Inventory (BAI), and depression levels evaluated with the Beck Depression Inventory (BDI). Attendance and absence data will also be collected, as well as information regarding program discontinuation.
Frequently Asked Questions
What is High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia?
High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia is a clinical trial registered under NCT07734662. Current status: COMPLETED.
What is the status of NCT07734662?
The current status of NCT07734662 (High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia) is: COMPLETED.
When did High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia start?
High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia started on 2024-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.